Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: Additional analyses from the AFFIRM randomized clinical trial

David Cella*, C. Ivanescu, S. Holmstrom, C. N. Bui, J. Spalding, K. Fizazi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: Additional analyses from the AFFIRM randomized clinical trial'. Together they form a unique fingerprint.

INIS

Nursing and Health Professions

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science